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Abstract
Background: While microRNAs (miRNAs) play important roles in tissue differentiation and in maintaining basal physiology,
little is known about the miRNA expression levels in stomach tissue. Alterations in the miRNA profile can lead to cell
deregulation, which can induce neoplasia.
Methodology/Principal Findings: A small RNA library of stomach tissue was sequenced using high-throughput SOLiD
sequencing technology. We obtained 261,274 quality reads with perfect matches to the human miRnome, and 42% of
known miRNAs were identified. Digital Gene Expression profiling (DGE) was performed based on read abundance and
showed that fifteen miRNAs were highly expressed in gastric tissue. Subsequently, the expression of these miRNAs was
validated in 10 healthy individuals by RT-PCR showed a significant correlation of 83.97% (P,0.05). Six miRNAs showed a low
variable pattern of expression (miR-29b, miR-29c, miR-19b, miR-31, miR-148a, miR-451) and could be considered part of the
expression pattern of the healthy gastric tissue.
Conclusions/Significance: This study aimed to validate normal miRNA profiles of human gastric tissue to establish a
reference profile for healthy individuals. Determining the regulatory processes acting in the stomach will be important in
the fight against gastric cancer, which is the second-leading cause of cancer mortality worldwide.
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Introduction
Recently, Friedman et al., 2009 demonstrated that the majority
of human genes are under the control of miRNAs. The .45,000
miRNA target sites within human 39UTRs are conserved, and
.60% of the human protein-coding genes have been under
selective pressure to maintain pairings to miRNAs [1]. miRNAs
are small, non-coding sequences of 17–25 bp that regulate gene
expression by binding to the 39 end of target mRNAs, resulting in
the inhibition of translation of the mRNAs [2,3]. Approximately
14,000 miRNAs have been identified in animals, plants and fungi
[4,5,6].
Mechanisms that involve miRNAs as negative regulators of
gene expression are similar in animals and plants; they regulate
fundamental cellular processes [6]. In humans, approximately 3%
of all genes are predicted to encode miRNA precursors, and over
.60% of protein-coding genes could be regulated by miRNAs [1].
MiRNAs have essential functions in many cellular processes such
as growth and development, cellular proliferation, differentiation
and apoptosis. Consequently, alterations in miRNA expression
contribute to human diseases such as cancers [7,8].
Alterations in miRNA expression patterns have been observed
in many types of human cancer, such as breast, colon, lung,
prostate, leukemia and stomach cancers. miRNA expression
alterations lead to a loss or gain of function and are associated
with the development of human neoplasm via diverse mechanisms
[5].
Here, we present a genetic study of the miRNA of the human
stomach, because despite the importance of the organ, little
genetic data are available on their presence and regulation in
humans. This work is the first full miRnome sequencing of normal
stomach tissue using next-generation sequencing technology.
Results
In the present study, profiles were obtained by ultra-deep
sequencing using the SOLiD platform (Life Technologies, CA,
US). This is the first study to use this procedure to describe the
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13205miRnome of normal gastric tissue. miRNAs were isolated from
normal gastric cardia mucosa of a single healthy patient. The
profiles were validated using Real Time PCR to determine the
expression of the 15 most highly expressed miRNAs in another 10
healthy patients.
ULTRA-DEEP SEQUENCING
Ultra-deep sequencing yielded a total of 104 million raw reads
and 5 million reads for the gastric cardia miRNA library. For
further analysis, 3.2 million reads were selected according to
sequence quality (at least QV$10 in the 10 first bases) [8]. After
mapping these to the human genome (release 19), the total
mapped read count was 2,534,490 million reads (75% of total
quality reads). Approximately 38% of 2.5 million reads (963,460
reads) were repetitive DNA sequences, tRNA, rRNA or other
small molecules; 10% (261,274) were accepted reads, perfectly
aligned with known mature miRNAs (MirBase version 15, release
04/2010) [9]; and the rest of the reads (52%) were matched to
genome sequences (Figure 1).
For the expression analysis of miRNAs, only reads with matches
to mature miRNAs sequences (261,274 reads) were included. In
gastric cardia, we identified 404 of 970 known mature miRNA
sequences (42%). To analyze the expression of miRNAs, we
defined five ranges: 1 to 10 read counts; 11 to 100; 101 to 1,000;
1,001 to 5,000; and a read count of over 5,000 (Figure 2)
(additional details are provided in Table S1). The first range (1–
10) comprised 40% of the miRNAs observed; the second range (11
to 100) comprised 26%; the third range (101 to 1,000) comprised
20%; and the fourth and fifth ranges (.1000 read count)
comprised 14%.
With this classification, 347 mature miRNAs were expressed
between the first and third ranges and 57 between the fourth and
fifth ranges. For the characterization of the miRnome, we selected
a set of the 15 miRNAs that were expressed at the highest levels
($1,000 reads).
Table 1 and Figure 3 list the 15 mature miRNAs identified in
the human gastric cardia. The heatmap of Figure 4 summarizes
the expression of these 15 miRNAs in the gastric cardia and across
normal human tissues, DGE data, available in the microRNA.org
databank [10,11]. Mature miRNA expression could be classified
into two groups: i) cardia-tissues: miRNAs rarely expressed in
other tissues but expressed in gastric cardia, including miR-148a,
miR-192, miR-200a and miR-200b; ii) quasi-ubiquitous: miRNAs
expressed in many tissues and conditions, including miR-29c,
miR-21, miR-24, miR-29b, miR-29a, miR-451, miR-31, miR-
145, miR-26a, miR-19b and let-7b.
REAL TIME PCR
The ultra-deep sequencing results were validated using the
singleplex Real Time PCR (RT-PCR) method on the 15 miRNAs
selected to determine their expression in the gastric cardia region
from 10 healthy individuals. Of the test subjects, 60% were males,
the mean age was 39.1 (612.8) years and 50% of the studied
subjects tested positive for H. pylori, according to international
criteria established for their identification [12,13] (Table 2)
(additional details are provided in Table S2).
COMPARARISON WITH DGE AND RT-PCR
Both singleplex (RT-PCR) and multiplex (SOLiD platform)
technologies showed high expression (expression over 1,000 reads
in the DGE and 7-fold above the endogenous control in the RT-
PCR) of the 15 miRNAs (Figures 4 and 5).
The same RNA samples had been analyzed by two different
platforms: DGE and RT-PCR - Life Technologies. The results
experiments were compared and were observed linear regression
between 2
2DCt and square root of read count number. Pearson
Figure 1. Distribution of small RNAs sequenced from human gastric cardia tissue using deep-sequencing.
doi:10.1371/journal.pone.0013205.g001
MicroRNA Expression of Stomach
PLoS ONE | www.plosone.org 2 October 2010 | Volume 5 | Issue 10 | e13205correlation is high 83.9% with statistical significant test (P,0.05)
and validated SOLID results.
Additionally, DGE results were compared to the quantification
of the expression range of the miRNAs in 10 healthy subjects, by
Real Time PCR. The regression for average of RT-PCR assays
versus square root of read count number. Pearson correlation is
high 68.4% with statistical significant test (P,0.05).
Could observe miRNAs with high interindividual variation, for
exempla miR-21, and another with low interindividual variation,
e.g. expression pattern slightly variable (miR-29b, miR-29c, miR-
19b, miR-31, miR-148a, miR-451).
Discussion
miRNAs regulate the majority of human genes; however, only a
few miRNAs have had their targets and specific functions
identified [14]. In our study, the stomach sample was obtained
from a single individual without stomach neoplasia or other pre-
neoplasia conditions such as atrophy, metaplasia or dysplasia. Pre-
cancerous lesions such as gastritis lead to genomic hypo-
methylation in the stomach that could modify the expression
pattern of miRNAs [15]. The sample was obtained from the
normal tissue from a patient without any pathologies, which
helped in avoiding the risk of collecting a seemingly normal tissue
sample with micro-invasions of early-stage tumorigenic cells as
could occur in patients with any of the above pathologies.
This study is the first ultra-high-throughput sequencing of
miRNAs in the physiologically normal human stomach. Only
5.06% of miRNAs identified in gastric tissue had already been
detected in other tissues and cataloged in bioinformatics databanks
such as microRNA.org [10]. We expect this group of miRNAs to
be regulators of housekeeping genes, which are abundant in
human tissues. Another 7.84% of miRNAs had no matches in the
miRNA expression databases and could represent miRNAs that
are specific to the digestive system or stomach.
Similar studies have been performed with other normal tissues,
such as the mouth, pharynx, esophagus, anus and intestine. We
compared these data with our miRNA expression data to define
the expression pattern of the stomach tissue. We found high
expression levels in 15 miRNAs, 13 of which had already been
identified as highly expressed in other tissues.
The expression of mir-148a and mir-192 had been identified in
other normal and cancerous human tissues, but was not over-
expressed. Mir-192 had already been detected in gastrointestinal
tissues such as the colon, ileum, duodenum, small intestine,
stomach, pancreas and liver [16]. Basal expression of mir-148a has
been observed in connective tissue and endocrine tissue [17].
Recently, mir-148a was found to be repressed in umbilical cord
blood cells [18] and silenced by hypermethylation in colon tumors
[19]. We observed high expression of the mir-200 cluster (a and b)
in gastric cardia as observed in the islets of Langerhans [11]. In a
microarray experiment, mir-200a and mir-200b were detected at
low levels in gastrointestinal tissues but at high levels in the colon,
stomach and pancreas [16]. A recently published microRNA
expression atlas showed that this miRNA is characteristic to
endocrine tissue [17]. Recent findings show that the low
expression of the mir-200 cluster is correlated with ovarian cancer
[19,20]. Therefore, the mir-200 cluster may be important in
maintaining the integrity of digestive tissues such as gastric cardia
because such high expression up-regulated the expression of e-
Figure 2. Distribution of microRNA by read count number in human gastric cardia. The read count is based on quantity of read detected
during the deep-sequencing of small RNA library of gastric cardia, using SOLiD system. For microRNA detection was used the miRBase release 15.0.
doi:10.1371/journal.pone.0013205.g002
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architecture of the epithelial tissue. Additionally, the results
strongly suggested an important role of the miR-200 family in
the repression of the epithelial-mesenchymal transition (EMT) and
the progression of cancer [21].
Table 1 and 2 show the number of possible targets for each
highly expressed mature miRNA. Table 2 shows some targets of
miRNAs predicted by the TargetScan against families of
conserved miRNAs. With the exception of miR-451, all shared
at least two other gene targets. The genes ANKD52 and UBN2, are
targets of ten of the fourteen miRNAs analyzed, while the gene
TNRC6B is of nine miRNAs, and the genes EPS15, NFAT5,
BACH2, BRWD1, NUFIP2, PTEN, CDK6, and PTPRD DD6, are
targets of eight miRNA. This result suggests that these miRNAs
are strong candidates to be silenced in cardia region. The
experimental validation of these genes, followed by an analysis of
the function of each one can reveal the physiological role of these
miRNAs in normal gastric tissue.
Many miRNAs may regulate the translation of proteins that
act in tissue proliferation and tissue patterning such as mir-200a
(which may target integrin) and mir-145 (which may interact
with ERBB4 mRNA). Many predicted mRNA targets were
f o u n dt ob ec o m m o nt om u l t i p l eh ighly expressed miRNAs. For
example, the HTR4 (5-hydroxytryptamine [serotonin] receptor)
and AFF2 mRNAs (AF4/FMR2 family, member 2) were
predicted to be targets of 13 of the 15 most highly expressed
miRNAs. Another five mRNAs, including IGF-1 (insulin-like
growth factor 1 [somatomedin C]), were common predicted
targets of 12 miRNAs. Eight miRNAs had 222 predicted targets
in common; for example, mir-29b was predicted to target 196 of
these. Five miRNAs (19b, 29a, 29b, 29c and 148a) shared 70
predicted targets, some of which (CDK6, PTEN, IGF1, FRS2,
PDGFRA, PIK3R1 and MXD1) regulate cellular proliferation and
tumor suppression.
Several observations link miRNAs to cancer. First, many
miRNAs are involved in cellular proliferation and apoptosis.
Second, many miRNA loci are located in fragile sites of the human
genome, regions that are frequently amplified or deleted in human
neoplasias and cause large differences in miRNA expression
compared with normal tissues [21,22,23,24].
The Real Time PCR technique (which uses relative quantifi-
cation) confirmed 15 miRNAs identified as showing the highest
expression by the SOLiD platform (which is based on absolute
numbers) (Figures 4 and 5). Therefore, these miRNAs can be
considered as being over-expressed [25,26,27,28]. The correlation
between DGE and RT-PCR assays was clear and statistic
significant. And DGE experiment could be considered represen-
tative of tissues gastric samples isolated from 10 health subjects and
define part of the expression pattern of the healthy gastric tissue.
The results from both methodologies indicate that miRNA-21
was the most highly expressed in gastric cardia tissue. This miRNA
is also distributed in other human tissues (e.g., dendritic cells, T-
cells, pancreas) and could be involved in regulating the expression
of housekeeping genes (ATPAF1, KIF3A, CYBRD1).
The SOLiD platform showed that miR-192 and 148a are
specific to gastric tissue. In addition, Real Time PCR confirmed
that these miRNAs are over-expressed. Thus, overall, these
miRNAs are likely to regulate the expression of genes related to
gastric tissue homeostasis. Therefore, the low expression levels of
these miRNAs could be related to the development of a stomach
neoplasia. The potential use of miRNA-192 and miRNA-148a as
risk markers in gastric cancer could be best investigated through
the analysis of the miRnomes of different histological types of
gastric cancer.
Table 1. Characteristics of the 15 most highly expressed microRNAs in human gastric cardia and number of possible targets
predicted.
miRNA isoform arm Read count Target number Highly expressed in other tissues
miR-29 c 3p 27511 2609 no
miR-21 5p 22945 2013 yes
miR-148 a 3p 19629 2830 no
miR-24 1 3p 17322 2729 no
2 3p 17282
miR-29 b2 3p 15099 2948 yes
b1 3p 14965
miR-192 5p 14417 1029 no
miR-29 a 3p 13723 2525 no
miR-451 5p 10064 3166 no
miR-145 5p 9286 603 no
miR-31 5p 7314 2192 no
miR-200 a 3p 7770 3070 no
miR-19 b2 3p 6477 3951 no
b1 3p 6474
miR-200 b 3p 2803 3421 no
let-7 b 5p 2800 2976 yes
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stomach will be important in the fight against gastric cancer, which
is the second-leading cause of cancer mortality worldwide.
Materials and Methods
BIOLOGICAL MATERIAL
The gastric cardia is a microscopic zone that is normally found
in the most proximal portion of the stomach, close to the
esophageal opening (cardiac orifice or cardia) and contains the
cardiac glands. Our fresh tissue sample for ultra deep sequencing
was obtained from a gastroscopic biopsy (,4m m
3). The patient
was 33 years old, with no evidence of cancer and a normal
gastroesophageal junction. Macroscopic observation of the tissue
showed no evidence of lesions, and histological examination
confirmed normal and healthy conditions.
To confirm the results of ultra-deep sequencing, cardia
samples, near cardiac orifice, from 10 addition, healthy indivi-
duals were also obtained by endoscopic biopsies (,4m m
3) and,
after histological examination excluding abnormalities, were
analyzed by Real Time PCR. H. pylori infection was diagnosed
based on the typical appearance of the bacterium along the mucus
layer covering the gastric mucous membrane Antral biopsies were
taken for histology evaluation due to higher density of the bacteria
in gastric antrum and to the excellent sensitivity of this diagnostic
method, according to international criteria established for
their identification [12,13] (additional details are provided in
Table S2).
ETHICS STATEMENT
Written informed consent was obtained from all patients, and
the study was approved by the Comite ˆd eE ´tica em Pesquisa (CEP)
of Hospital Universita ´rio Joa ˜o Barros Barreto (HUJBB) - Federal
University of Para ´ (UFPA) (Protocol number 14052004/HUJBB).
miRNA LIBRARY
The total small RNA was obtained from the sample tissue using
the mirVana Isolation Kit (Ambion Inc., US). The concentration
and quality were determined using a Nanodrop 1000 spectropho-
tometer, and purification and size selection were performed using
6% polyacrylamide gel electrophoresis. Using the SOLiD Small
RNA Expression Kit (Ambion Inc., US), 200 ng of small RNA of
150–200 bp were used as a template to obtain the miRNA library.
All miRNAs of the library were tagged with unique and specific
amplification primers, known as the barcode system (Life
Technologies, CA, US). Then, 50 pg of the library was pooled
with seven other miRNA libraries at the same concentration. A
Figure 3. Most expressed microRNAs in human gastric cardia. The read count is based on quantity of read detected during the deep-
sequencing of small RNA library of gastric cardia, using SOLiD system.
doi:10.1371/journal.pone.0013205.g003
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magnetic beads using emulsion PCR. The ePCR product was
deposited on a single slide and subjected to the multiplex SOLiD
sequencing reaction.
SOLiD ULTRA-DEEP SEQUENCING AND DATA ANALYSIS
The SOLiD (version 2.0) sequencing system (Life Technologies)
was used to generate reads that were 35 bp long. The second step
was to decode the barcode, matching each bead sequence with the
identity of the sample. All small RNA sequences of gastric cardia
are available in the NCBI Sequences Read Archive (SRA012099).
Sequence analysis was performed using the SOLiD System Small
RNA Analysis Tool (Life Technologies) and MiRanalyzer [8].
First, we filtered out all sequences that matched RNA contami-
nants such as tRNA, rRNA, DNA repeats and adaptor molecules.
After excluding contaminant reads, we aligned all sequences
against miRNA precursor sequences (MirBase ver. 12) and then
only included the reads that matched mature miRNA sequences
[9]. To compare these expression data with those of other human
tissues, miRNA expression data were imported from the micro-
RNA.org database, and the expression of each mature miRNA
was normalized by total read count [10]. Graphical analysis was
performed using Genepattern
10. The miRNA–biological process
relationships were predicted using miRNApath (http://lgmb.
fmrp.usp.br/mirnapath/tools.php).
miRNA REAL TIME PCR (VALIDATION)
Biopsy samples of gastric cardia tissues were collected from 10
healthy patients. After collection, the samples were immediately
processed and stored at 280uC until RNA extraction. Total RNA
Figure 4. Heatmap of normalized expression of the 15 most expressed mature miRNAs in human gastric tissue and their
comparison with other normal tissues published in the mammalian microRNA expression atlas (Landgraf, P. et al. (2007). Cell 129:
1401–1414). The heatmap was generated using gene pattern software with normalized expression of microRNA (read count number for specific
microRNA/total of count number of microRNA). Color scale indicates the percent of total count reads number 0 to 0.2 (0 to 20%). Human tissue
description and abbreviation: hsa_B-cell-CD19 (B cells from peripheral blood); hsa_B-cell-CD19-pool (B cells from peripheral blood (pool from 4
healthy donors)); hsa_B-cell-CD19-2 (B cells from peripheral blood); hsa_DC-unstim (myeloid dendritic cells not stimulated); hsa_DC-stim (myeloid
dendritic cells stimulated with endotoxin); hsa_DC-unstim (myeloid dendritic cells not stimulated); hsa_DC-stim (myeloid dendritic cells stimulated
with endotoxin); hsa_Fibrobl-CMV(Foreskin fibroblasts; Primary fibroblasts lytically infected with Cytomegalovirus); hsa_Frontal-cortex-adult;
(Brain_normal adult; sample from Brodman area 9 (superior frontal gyrus) of a 20 year old healthy male, 6 hours postmortem); hsa_Granulocytes-CD1;
(Granulocytes; Granulocyte cells from peripheral blood (pool from 4 healthy donors)); hsa_HSC-CD34 (pluripotent hematopoetic stem cell CD34+ -
sorted cells); hsa_NK-CD56;(NK cells from peripheral blood (pool from 4 healthy donors)); hsa_Podocytes-Moins-undiff (Podocytes_undifferentiated);
hsa_Podocytes-Moins-diff (Podocytes_differentiated); hsa_T-cell-CD4 (T helper cells, peripheral blood (pool from 4 healthy donors)); hsa_T-cell-CD4-2
(T helper cells); hsa_T-cell-CD4-naive(CD4+ CD45 RA+(CD45RO2) native cells); hsa_T-cell-CD4-effector (CD4+, CD45RO+, CD272, CCR72. Effector
cells); hsa_T-cell-CD4-memory (CD4+CD45RO+(CD45RA2) memory cells); hsa_T-cell-CD8-2 (cytotoxic T-cells); hsa_T-cell-CD8 (cytotoxic T-cells,
peripheral blood(pool from 4 healthy donors); hsa_T-cell-CD8-naive (CD8+, CD45RA+, CD27+, CCR7+); hsa_USSC (unrestricted somatic stem cells from
umbilical cord); hsa_USSC-d1(unrestricted somatic stem cells from umbilical cord induced 1 day to osteoblasts); hsa_USSC-d3 (unrestricted somatic
stem cells from umbilical cord induced 3 day to osteoblasts); hsa_USSC-d7 (unrestricted somatic stem cells from umbilical cord induced 7 day to
osteoblasts).
doi:10.1371/journal.pone.0013205.g004
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miRNAs TargetScan’s putatives targets
hsa-miR-19 UBN2; TNRC6B; EPS15; BRWD1; NUFIP2; PTEN; PTPRD; DDX6; IGF1; KIAA0355; CNOT6; GMFB; PLXNA4; ATXN1; DICER1; SCML2; PIK3R3;
KLF12; PDIK1L; CREB5.
hsa-miR-29a ANKRD52; UBN2; TNRC6B; EPS15; NFAT5; BACH2; BRWD1; NUFIP2; PTEN; CDK6; PTPRD; DDX6; IGF1; KIAA2018; KIAA0355; CNOT6;
GMFB; SH3PXD2A; KLF4; SLC16A2.
hsa-miR-29c ANKRD52; UBN2; TNRC6B; EPS15; NFAT5; BACH2; BRWD1; NUFIP2; PTEN; CDK6; PTPRD; DDX6; IGF1; KIAA2018; KIAA0355; CNOT6;
GMFB; SH3PXD2A; KLF4; SLC16A2.
hsa-miR-29b ANKRD52; UBN2; TNRC6B; EPS15; NFAT5; BACH2; BRWD1; NUFIP2; PTEN; CDK6; PTPRD; DDX6; IGF1; KIAA2018; KIAA0355; CNOT6;
GMFB; SH3PXD2A; KLF4; SLC16A2.
hsa-miR-200b ANKRD52; UBN2; EPS15; BACH2; BRWD1; NUFIP2; PTEN; DDX6; KIAA2018; KIAA0355; CNOT6; SH3PXD2A; KLF4; SLC16A2; PLXNA4;
ATXN1; KLF12; SNTB2; PDIK1L; CREB5.
hsa-miR-26a ANKRD52; UBN2; TNRC6B; EPS15; BRWD1; PTEN; CDK6; PTPRD; IGF1; KIAA2018; GMFB; SH3PXD2A; KLF4; C11orf41; PIK3R3; PDIK1L;
TP53INP1; CCND2; PTP4A1; MIB1.
hsa-miR-148a ANKRD52; UBN2; TNRC6B; EPS15; NFAT5; BACH2; PTEN; CDK6; PTPRD; DDX6; IGF1; CNOT6; GMFB; SH3PXD2A; KLF4; ATXN1; DICER1;
SCML2; PIK3R3; SP1.
hsa-miR-200a ANKRD52; TNRC6B; BACH2; BRWD1; NUFIP2; PTEN; CDK6; PTPRD; PLXNA4; ATXN1; C11orf41; KLF12; PLAG1; TP53INP1; ELF2; CCND2;
PTP4A1; MIB1; PHF21A; TET3.
hsa-miR-145 ANKRD52; UBN2; EPS15; BACH2; NUFIP2; CDK6; DDX6; KIAA0355; GMFB; KLF4; SLC16A2; SNTB2; PDIK1L; CREB5; NFIB; SP1; ELF2;
CCND2; PHF21A; ADAM19.
hsa-miR-24 ANKRD52; UBN2; NFAT5; PTPRD; KIAA2018; KIAA0355; CNOT6; SH3PXD2A; SLC16A2; C11orf41; SCML2; PIK3R3; SP1; PLAG1; TP53INP1;
ADAM19; PHLPPL; AMMECR1; CALCR; CSNK1G1.
hsa-miR-31 ANKRD52; TNRC6B; NFAT5; BACH2; NUFIP2; KIAA2018; SLC16A2; PLXNA4; C11orf41; DICER1; SNTB2; ELAVL2; CCNJ; CALCR; BAHD1;
RHOBTB1; ZBTB34; RAPH1; SLC1A2; JAZF1.
hsa-miR-21 UBN2;TNRC6B;NFAT5;BRWD1;CDK6;SCML2;KLF12;SNTB2;NFIB;PLAG1;ELF2; CPEB3; GLIS2; TIAM1; BAHD1; TET1; PAG1; STK38L; ZNF217; BCL11A.
hsa-miR-192 NFAT5; DDX6; IGF1; DICER1; CREB5; C6orf168; CTNNBIP1; ZBTB34; COL5A1; PPP1R3D; NCOA3; XPO4; SLC5A3; SH3RF3; CDON; DIAPH2; DBT;
FAM167A; CCNT2; IKZF2.
hsa-miR-451 GATAD2B; C11orf30; TSC1; VAPA; OSR1; FBXO33; CAB39; YWHAZ; PSMB8; SAMD4B; GK; AEBP2; CDKN2D; TTN.
Putative targets of the miRNAs were predict by TargeScan 5.1. Genes marked in bold type are targets of at least two miRNAs listed above.
doi:10.1371/journal.pone.0013205.t002
Figure 5. Quantification by Real Time PCR of high expressed microRNAs in human gastric cardia. The quantification is based on Ct and
was normalized by endogenous expression control. The 2
2DCt for each miR is the mean of ten determination originated from gastric cardia tissue of
ten different individuals.
doi:10.1371/journal.pone.0013205.g005
MicroRNA Expression of Stomach
PLoS ONE | www.plosone.org 7 October 2010 | Volume 5 | Issue 10 | e13205was extracted by homogenizing 40 milligrams of frozen tissue,
followed by RNA isolation by TRIzol reagent (Life Technologies)
according to the manufacturer’s instructions. The concentration
and quality of miRNAs were determined using a Nanodrop 1000
spectrophotometer (ND-1000; Nanodrop Technologies, Wilming-
ton, DE). Total RNA was reverse transcribed using a TaqMan@-
MicroRNA Reverse Transcription kit (Life Technologies).
The analysis of miRNAs levels was performed on a 7500 Real-
Time PCR System (Life Technologies) with TaqMan miRNA
assays according to the manufacturer’s instructions (Life Technol-
ogies) using primers designed with Primer Express (Life Technol-
ogies). The mean expression level of three human endogenous
controls (Z30, RNU19 and RNU6B - calibrators) was used as an
internal control in all miRNA experiments to allow for the
comparison of expression results.
The high expression levels of miRNAs identified by ultra-deep
sequencing (in descending order: miR-29c, miR-21, miR-148a,
miR-29a, miR-24, miR-29b, miR-192, miR-451, miR-145, miR-
31, miR-200a, miR-19b, miR-200b, let-7b and miR-26a) were
validated with the TaqMan miRNA assays (Life Technologies).
These analyses were used to measure the expression levels of
mature miRNAs and the inter-individual variation in the 10
samples of healthy cardia tissue. The expression data of each
mature miRNA were normalized to the mean expression level of
the three human endogenous controls (Z30, RNU19 and
RNU6B). The relative miRNA expression levels were then
calculated by the comparative threshold cycle (Ct) method
(2
2DCt). Correlation test was performed using Pearson method
(SPSS v.12).
Supporting Information
Table S1 Identity and abundance data for all known miRNAs in
SOLiD sequence dataset in human stomach and miRamda
database.
Found at: doi:10.1371/journal.pone.0013205.s001 (0.44 MB
PDF)
Table S2 Description and RT-PCR results of 10 samples from
healthy individuals obtained by endoscopic biopsies. Samples size
is about ,4 mm3. For all samples were performed a histological
examination and H. pylori detection.
Found at: doi:10.1371/journal.pone.0013205.s002 (0.03 MB
XLS)
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